Nova Leap Health Corp. (NLH.V)

CAD 0.25

(-5.66%)

EBITDA Summary of Nova Leap Health Corp.

Nova Leap Health Corp.'s latest annual EBITDA in 2023 was 994.46 Thousand USD , up 287.87% from previous year.
Nova Leap Health Corp.'s latest quarterly EBITDA in 2024 Q1 was 330.77 Thousand USD , down -25.36% from previous quarter.
Nova Leap Health Corp. reported an annual EBITDA of 420.35 Thousand USD in 2022, down -94.61% from previous year.
Nova Leap Health Corp. reported an annual EBITDA of 4.75 Million USD in 2021, up 101.58% from previous year.
Nova Leap Health Corp. reported a quarterly EBITDA of 330.77 Thousand USD for 2024 Q1, down -25.36% from previous quarter.
Nova Leap Health Corp. reported a quarterly EBITDA of 451.45 Thousand USD for 2023 Q4, up 10.87% from previous quarter.

Annual EBITDA Chart of Nova Leap Health Corp. (2023 - 2016)

Historical Annual EBITDA of Nova Leap Health Corp. (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	994.46 Thousand USD	287.87%
2022	420.35 Thousand USD	-94.61%
2021	4.75 Million USD	101.58%
2020	2.35 Million USD	366.34%
2019	128.28 Thousand USD	257.58%
2018	-284.93 Thousand USD	60.89%
2017	-868.42 Thousand USD	-77.77%
2016	-461.66 Thousand USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	380.4 Thousand USD	14.72%
2024 Q1	330.77 Thousand USD	-25.36%
2023 Q4	451.45 Thousand USD	10.87%
2023 Q1	48.98 Thousand USD	324.83%
2023 Q2	366.43 Thousand USD	648.1%
2023 Q3	407.19 Thousand USD	11.12%
2022 Q1	121.07 Thousand USD	134.59%
2022 FY	- USD	-94.61%
2022 Q4	-21.78 Thousand USD	-109.79%
2022 Q3	222.59 Thousand USD	439.9%
2022 Q2	-65.48 Thousand USD	-154.09%
2021 Q2	1.68 Million USD	6.24%
2021 FY	- USD	101.58%
2021 Q3	1.83 Million USD	9.34%
2021 Q4	-349.99 Thousand USD	-119.03%
2021 Q1	1.58 Million USD	131.99%
2020 Q1	156.06 Thousand USD	471.16%
2020 Q2	379.16 Thousand USD	142.96%
2020 FY	- USD	366.34%
2020 Q4	682.58 Thousand USD	-40.18%
2020 Q3	1.14 Million USD	200.96%
2019 Q2	166.72 Thousand USD	328.21%
2019 Q1	38.93 Thousand USD	136.42%
2019 Q4	27.32 Thousand USD	-89.99%
2019 FY	- USD	257.58%
2019 Q3	272.85 Thousand USD	63.65%
2018 Q4	-106.91 Thousand USD	-807.6%
2018 Q1	-255.61 Thousand USD	-0.01%
2018 Q2	16.99 Thousand USD	106.65%
2018 FY	- USD	60.89%
2018 Q3	15.1 Thousand USD	-11.12%
2017 Q4	-255.59 Thousand USD	-9.15%
2017 Q2	-162.73 Thousand USD	2.0%
2017 FY	- USD	-77.77%
2017 Q1	-166.05 Thousand USD	0.0%
2017 Q3	-234.17 Thousand USD	-43.9%
2016 Q2	-79.74 Thousand USD	17.8%
2016 Q3	-192.32 Thousand USD	-141.16%
2016 Q1	-97.01 Thousand USD	0.0%
2016 FY	- USD	0.0%

Peer EBITDA Comparison of Nova Leap Health Corp.

Name	EBITDA	EBITDA Difference
Jack Nathan Medical Corp.	-4.95 Million CAD	120.071%
Premier Health of America Inc.	5.86 Million CAD	83.05%